The global market for Veterinary Antiparasitic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Parasitic infections are very common in the livestock industry and have serious consequences for animal health and performance. Therefore, the use of antiparasitic drugs is an important means of preventing and treating parasitic infections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Antiparasitic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Antiparasitic Drugs.

The Veterinary Antiparasitic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Antiparasitic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Veterinary Antiparasitic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Antiparasitic Drugs Market Report

Report Metric	Details
Report Name	Veterinary Antiparasitic Drugs Market
Segment by Type	Antihelmintics Antiprotozoal Drugs
Segment by Application	Farm Zoo Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Weefsel Pharma, Meiji Group, Biowet, HPRA, Medinfar Sorologico, Boehringer Ingelheim Animal Health, VET -AGRO, Mobedco, Merck KGaA, VIC, Vetsintez, Cadila Pharmaceuticals, Watson International Limited, VivaldisGlenmark Pharmaceuticals Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Antiparasitic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Antiparasitic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Veterinary Antiparasitic Drugs Market report?

Ans: The main players in the Veterinary Antiparasitic Drugs Market are Weefsel Pharma, Meiji Group, Biowet, HPRA, Medinfar Sorologico, Boehringer Ingelheim Animal Health, VET -AGRO, Mobedco, Merck KGaA, VIC, Vetsintez, Cadila Pharmaceuticals, Watson International Limited, VivaldisGlenmark Pharmaceuticals Limited

What are the Application segmentation covered in the Veterinary Antiparasitic Drugs Market report?

Ans: The Applications covered in the Veterinary Antiparasitic Drugs Market report are Farm, Zoo, Others

What are the Type segmentation covered in the Veterinary Antiparasitic Drugs Market report?

Ans: The Types covered in the Veterinary Antiparasitic Drugs Market report are Antihelmintics, Antiprotozoal Drugs

1 Veterinary Antiparasitic Drugs Market Overview

1.1 Product Definition

1.2 Veterinary Antiparasitic Drugs by Type

1.2.1 Global Veterinary Antiparasitic Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Antihelmintics

1.2.3 Antiprotozoal Drugs

1.3 Veterinary Antiparasitic Drugs by Application

1.3.1 Global Veterinary Antiparasitic Drugs Market Value by Application (2024 VS 2031)

1.3.2 Farm

1.3.3 Zoo

1.3.4 Others

1.4 Global Veterinary Antiparasitic Drugs Market Size Estimates and Forecasts

1.4.1 Global Veterinary Antiparasitic Drugs Revenue 2020-2031

1.4.2 Global Veterinary Antiparasitic Drugs Sales 2020-2031

1.4.3 Global Veterinary Antiparasitic Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Veterinary Antiparasitic Drugs Market Competition by Manufacturers

2.1 Global Veterinary Antiparasitic Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Veterinary Antiparasitic Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Veterinary Antiparasitic Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Veterinary Antiparasitic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Veterinary Antiparasitic Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Veterinary Antiparasitic Drugs, Product Type & Application

2.7 Global Key Manufacturers of Veterinary Antiparasitic Drugs, Date of Enter into This Industry

2.8 Global Veterinary Antiparasitic Drugs Market Competitive Situation and Trends

2.8.1 Global Veterinary Antiparasitic Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Veterinary Antiparasitic Drugs Players Market Share by Revenue

2.8.3 Global Veterinary Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Veterinary Antiparasitic Drugs Market Scenario by Region

3.1 Global Veterinary Antiparasitic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Veterinary Antiparasitic Drugs Sales by Region: 2020-2031

3.2.1 Global Veterinary Antiparasitic Drugs Sales by Region: 2020-2025

3.2.2 Global Veterinary Antiparasitic Drugs Sales by Region: 2026-2031

3.3 Global Veterinary Antiparasitic Drugs Revenue by Region: 2020-2031

3.3.1 Global Veterinary Antiparasitic Drugs Revenue by Region: 2020-2025

3.3.2 Global Veterinary Antiparasitic Drugs Revenue by Region: 2026-2031

3.4 North America Veterinary Antiparasitic Drugs Market Facts & Figures by Country

3.4.1 North America Veterinary Antiparasitic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Veterinary Antiparasitic Drugs Sales by Country (2020-2031)

3.4.3 North America Veterinary Antiparasitic Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Veterinary Antiparasitic Drugs Market Facts & Figures by Country

3.5.1 Europe Veterinary Antiparasitic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Veterinary Antiparasitic Drugs Sales by Country (2020-2031)

3.5.3 Europe Veterinary Antiparasitic Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Veterinary Antiparasitic Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Veterinary Antiparasitic Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Veterinary Antiparasitic Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Veterinary Antiparasitic Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Veterinary Antiparasitic Drugs Market Facts & Figures by Country

3.7.1 Latin America Veterinary Antiparasitic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Veterinary Antiparasitic Drugs Sales by Country (2020-2031)

3.7.3 Latin America Veterinary Antiparasitic Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Veterinary Antiparasitic Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Veterinary Antiparasitic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Veterinary Antiparasitic Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Veterinary Antiparasitic Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Veterinary Antiparasitic Drugs Sales by Type (2020-2031)

4.1.1 Global Veterinary Antiparasitic Drugs Sales by Type (2020-2025)

4.1.2 Global Veterinary Antiparasitic Drugs Sales by Type (2026-2031)

4.1.3 Global Veterinary Antiparasitic Drugs Sales Market Share by Type (2020-2031)

4.2 Global Veterinary Antiparasitic Drugs Revenue by Type (2020-2031)

4.2.1 Global Veterinary Antiparasitic Drugs Revenue by Type (2020-2025)

4.2.2 Global Veterinary Antiparasitic Drugs Revenue by Type (2026-2031)

4.2.3 Global Veterinary Antiparasitic Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Veterinary Antiparasitic Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Veterinary Antiparasitic Drugs Sales by Application (2020-2031)

5.1.1 Global Veterinary Antiparasitic Drugs Sales by Application (2020-2025)

5.1.2 Global Veterinary Antiparasitic Drugs Sales by Application (2026-2031)

5.1.3 Global Veterinary Antiparasitic Drugs Sales Market Share by Application (2020-2031)

5.2 Global Veterinary Antiparasitic Drugs Revenue by Application (2020-2031)

5.2.1 Global Veterinary Antiparasitic Drugs Revenue by Application (2020-2025)

5.2.2 Global Veterinary Antiparasitic Drugs Revenue by Application (2026-2031)

5.2.3 Global Veterinary Antiparasitic Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Veterinary Antiparasitic Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Weefsel Pharma

6.1.1 Weefsel Pharma Company Information

6.1.2 Weefsel Pharma Description and Business Overview

6.1.3 Weefsel Pharma Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Weefsel Pharma Veterinary Antiparasitic Drugs Product Portfolio

6.1.5 Weefsel Pharma Recent Developments/Updates

6.2 Meiji Group

6.2.1 Meiji Group Company Information

6.2.2 Meiji Group Description and Business Overview

6.2.3 Meiji Group Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Meiji Group Veterinary Antiparasitic Drugs Product Portfolio

6.2.5 Meiji Group Recent Developments/Updates

6.3 Biowet

6.3.1 Biowet Company Information

6.3.2 Biowet Description and Business Overview

6.3.3 Biowet Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Biowet Veterinary Antiparasitic Drugs Product Portfolio

6.3.5 Biowet Recent Developments/Updates

6.4 HPRA

6.4.1 HPRA Company Information

6.4.2 HPRA Description and Business Overview

6.4.3 HPRA Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 HPRA Veterinary Antiparasitic Drugs Product Portfolio

6.4.5 HPRA Recent Developments/Updates

6.5 Medinfar Sorologico

6.5.1 Medinfar Sorologico Company Information

6.5.2 Medinfar Sorologico Description and Business Overview

6.5.3 Medinfar Sorologico Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Medinfar Sorologico Veterinary Antiparasitic Drugs Product Portfolio

6.5.5 Medinfar Sorologico Recent Developments/Updates

6.6 Boehringer Ingelheim Animal Health

6.6.1 Boehringer Ingelheim Animal Health Company Information

6.6.2 Boehringer Ingelheim Animal Health Description and Business Overview

6.6.3 Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Product Portfolio

6.6.5 Boehringer Ingelheim Animal Health Recent Developments/Updates

6.7 VET -AGRO

6.7.1 VET -AGRO Company Information

6.7.2 VET -AGRO Description and Business Overview

6.7.3 VET -AGRO Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 VET -AGRO Veterinary Antiparasitic Drugs Product Portfolio

6.7.5 VET -AGRO Recent Developments/Updates

6.8 Mobedco

6.8.1 Mobedco Company Information

6.8.2 Mobedco Description and Business Overview

6.8.3 Mobedco Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mobedco Veterinary Antiparasitic Drugs Product Portfolio

6.8.5 Mobedco Recent Developments/Updates

6.9 Merck KGaA

6.9.1 Merck KGaA Company Information

6.9.2 Merck KGaA Description and Business Overview

6.9.3 Merck KGaA Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Merck KGaA Veterinary Antiparasitic Drugs Product Portfolio

6.9.5 Merck KGaA Recent Developments/Updates

6.10 VIC

6.10.1 VIC Company Information

6.10.2 VIC Description and Business Overview

6.10.3 VIC Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 VIC Veterinary Antiparasitic Drugs Product Portfolio

6.10.5 VIC Recent Developments/Updates

6.11 Vetsintez

6.11.1 Vetsintez Company Information

6.11.2 Vetsintez Description and Business Overview

6.11.3 Vetsintez Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Vetsintez Veterinary Antiparasitic Drugs Product Portfolio

6.11.5 Vetsintez Recent Developments/Updates

6.12 Cadila Pharmaceuticals

6.12.1 Cadila Pharmaceuticals Company Information

6.12.2 Cadila Pharmaceuticals Description and Business Overview

6.12.3 Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Product Portfolio

6.12.5 Cadila Pharmaceuticals Recent Developments/Updates

6.13 Watson International Limited

6.13.1 Watson International Limited Company Information

6.13.2 Watson International Limited Description and Business Overview

6.13.3 Watson International Limited Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Watson International Limited Veterinary Antiparasitic Drugs Product Portfolio

6.13.5 Watson International Limited Recent Developments/Updates

6.14 VivaldisGlenmark Pharmaceuticals Limited

6.14.1 VivaldisGlenmark Pharmaceuticals Limited Company Information

6.14.2 VivaldisGlenmark Pharmaceuticals Limited Description and Business Overview

6.14.3 VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Product Portfolio

6.14.5 VivaldisGlenmark Pharmaceuticals Limited Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Veterinary Antiparasitic Drugs Industry Chain Analysis

7.2 Veterinary Antiparasitic Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Veterinary Antiparasitic Drugs Production Mode & Process Analysis

7.4 Veterinary Antiparasitic Drugs Sales and Marketing

7.4.1 Veterinary Antiparasitic Drugs Sales Channels

7.4.2 Veterinary Antiparasitic Drugs Distributors

7.5 Veterinary Antiparasitic Drugs Customer Analysis

8 Veterinary Antiparasitic Drugs Market Dynamics

8.1 Veterinary Antiparasitic Drugs Industry Trends

8.2 Veterinary Antiparasitic Drugs Market Drivers

8.3 Veterinary Antiparasitic Drugs Market Challenges

8.4 Veterinary Antiparasitic Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Weefsel Pharma

Meiji Group

HPRA

Boehringer Ingelheim Animal Health

Mobedco

Cadila Pharmaceuticals

Watson International Limited

VivaldisGlenmark Pharmaceuticals Limited

List of Tables

Table 1. Global Veterinary Antiparasitic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Veterinary Antiparasitic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Veterinary Antiparasitic Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Veterinary Antiparasitic Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Veterinary Antiparasitic Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Veterinary Antiparasitic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Veterinary Antiparasitic Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Veterinary Antiparasitic Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Veterinary Antiparasitic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Veterinary Antiparasitic Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Veterinary Antiparasitic Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Veterinary Antiparasitic Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Veterinary Antiparasitic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Antiparasitic Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Veterinary Antiparasitic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Veterinary Antiparasitic Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Veterinary Antiparasitic Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Veterinary Antiparasitic Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Veterinary Antiparasitic Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Veterinary Antiparasitic Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Veterinary Antiparasitic Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Veterinary Antiparasitic Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Veterinary Antiparasitic Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Veterinary Antiparasitic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Veterinary Antiparasitic Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Veterinary Antiparasitic Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Veterinary Antiparasitic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Veterinary Antiparasitic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Veterinary Antiparasitic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Veterinary Antiparasitic Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Veterinary Antiparasitic Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Veterinary Antiparasitic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Veterinary Antiparasitic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Veterinary Antiparasitic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Veterinary Antiparasitic Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Veterinary Antiparasitic Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Veterinary Antiparasitic Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Veterinary Antiparasitic Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Veterinary Antiparasitic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Veterinary Antiparasitic Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Veterinary Antiparasitic Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Veterinary Antiparasitic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Veterinary Antiparasitic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Veterinary Antiparasitic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Veterinary Antiparasitic Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Veterinary Antiparasitic Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Veterinary Antiparasitic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Veterinary Antiparasitic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Veterinary Antiparasitic Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Veterinary Antiparasitic Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Veterinary Antiparasitic Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Veterinary Antiparasitic Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Veterinary Antiparasitic Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Veterinary Antiparasitic Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Veterinary Antiparasitic Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Veterinary Antiparasitic Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Veterinary Antiparasitic Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Veterinary Antiparasitic Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Veterinary Antiparasitic Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Veterinary Antiparasitic Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Veterinary Antiparasitic Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Veterinary Antiparasitic Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Veterinary Antiparasitic Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Veterinary Antiparasitic Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Veterinary Antiparasitic Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Veterinary Antiparasitic Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Veterinary Antiparasitic Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Veterinary Antiparasitic Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Weefsel Pharma Company Information

Table 71. Weefsel Pharma Description and Business Overview

Table 72. Weefsel Pharma Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Weefsel Pharma Veterinary Antiparasitic Drugs Product

Table 74. Weefsel Pharma Recent Developments/Updates

Table 75. Meiji Group Company Information

Table 76. Meiji Group Description and Business Overview

Table 77. Meiji Group Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Meiji Group Veterinary Antiparasitic Drugs Product

Table 79. Meiji Group Recent Developments/Updates

Table 80. Biowet Company Information

Table 81. Biowet Description and Business Overview

Table 82. Biowet Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Biowet Veterinary Antiparasitic Drugs Product

Table 84. Biowet Recent Developments/Updates

Table 85. HPRA Company Information

Table 86. HPRA Description and Business Overview

Table 87. HPRA Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. HPRA Veterinary Antiparasitic Drugs Product

Table 89. HPRA Recent Developments/Updates

Table 90. Medinfar Sorologico Company Information

Table 91. Medinfar Sorologico Description and Business Overview

Table 92. Medinfar Sorologico Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Medinfar Sorologico Veterinary Antiparasitic Drugs Product

Table 94. Medinfar Sorologico Recent Developments/Updates

Table 95. Boehringer Ingelheim Animal Health Company Information

Table 96. Boehringer Ingelheim Animal Health Description and Business Overview

Table 97. Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Product

Table 99. Boehringer Ingelheim Animal Health Recent Developments/Updates

Table 100. VET -AGRO Company Information

Table 101. VET -AGRO Description and Business Overview

Table 102. VET -AGRO Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. VET -AGRO Veterinary Antiparasitic Drugs Product

Table 104. VET -AGRO Recent Developments/Updates

Table 105. Mobedco Company Information

Table 106. Mobedco Description and Business Overview

Table 107. Mobedco Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Mobedco Veterinary Antiparasitic Drugs Product

Table 109. Mobedco Recent Developments/Updates

Table 110. Merck KGaA Company Information

Table 111. Merck KGaA Description and Business Overview

Table 112. Merck KGaA Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Merck KGaA Veterinary Antiparasitic Drugs Product

Table 114. Merck KGaA Recent Developments/Updates

Table 115. VIC Company Information

Table 116. VIC Description and Business Overview

Table 117. VIC Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. VIC Veterinary Antiparasitic Drugs Product

Table 119. VIC Recent Developments/Updates

Table 120. Vetsintez Company Information

Table 121. Vetsintez Description and Business Overview

Table 122. Vetsintez Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Vetsintez Veterinary Antiparasitic Drugs Product

Table 124. Vetsintez Recent Developments/Updates

Table 125. Cadila Pharmaceuticals Company Information

Table 126. Cadila Pharmaceuticals Description and Business Overview

Table 127. Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Product

Table 129. Cadila Pharmaceuticals Recent Developments/Updates

Table 130. Watson International Limited Company Information

Table 131. Watson International Limited Description and Business Overview

Table 132. Watson International Limited Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Watson International Limited Veterinary Antiparasitic Drugs Product

Table 134. Watson International Limited Recent Developments/Updates

Table 135. VivaldisGlenmark Pharmaceuticals Limited Company Information

Table 136. VivaldisGlenmark Pharmaceuticals Limited Description and Business Overview

Table 137. VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Product

Table 139. VivaldisGlenmark Pharmaceuticals Limited Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Veterinary Antiparasitic Drugs Distributors List

Table 143. Veterinary Antiparasitic Drugs Customers List

Table 144. Veterinary Antiparasitic Drugs Market Trends

Table 145. Veterinary Antiparasitic Drugs Market Drivers

Table 146. Veterinary Antiparasitic Drugs Market Challenges

Table 147. Veterinary Antiparasitic Drugs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Veterinary Antiparasitic Drugs

Figure 2. Global Veterinary Antiparasitic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Veterinary Antiparasitic Drugs Market Share by Type: 2024 & 2031

Figure 4. Antihelmintics Product Picture

Figure 5. Antiprotozoal Drugs Product Picture

Figure 6. Global Veterinary Antiparasitic Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Veterinary Antiparasitic Drugs Market Share by Application: 2024 & 2031

Figure 8. Farm

Figure 9. Zoo

Figure 10. Others

Figure 11. Global Veterinary Antiparasitic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Veterinary Antiparasitic Drugs Market Size (2020-2031) & (US$ Million)

Figure 13. Global Veterinary Antiparasitic Drugs Sales (2020-2031) & (K Units)

Figure 14. Global Veterinary Antiparasitic Drugs Average Price (US$/Unit) & (2020-2031)

Figure 15. Veterinary Antiparasitic Drugs Report Years Considered

Figure 16. Veterinary Antiparasitic Drugs Sales Share by Manufacturers in 2024

Figure 17. Global Veterinary Antiparasitic Drugs Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Veterinary Antiparasitic Drugs Players: Market Share by Revenue in Veterinary Antiparasitic Drugs in 2024

Figure 19. Veterinary Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Veterinary Antiparasitic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Veterinary Antiparasitic Drugs Sales Market Share by Country (2020-2031)

Figure 22. North America Veterinary Antiparasitic Drugs Revenue Market Share by Country (2020-2031)

Figure 23. United States Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Veterinary Antiparasitic Drugs Sales Market Share by Country (2020-2031)

Figure 26. Europe Veterinary Antiparasitic Drugs Revenue Market Share by Country (2020-2031)

Figure 27. Germany Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Veterinary Antiparasitic Drugs Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Veterinary Antiparasitic Drugs Revenue Market Share by Region (2020-2031)

Figure 34. China Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Veterinary Antiparasitic Drugs Sales Market Share by Country (2020-2031)

Figure 42. Latin America Veterinary Antiparasitic Drugs Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Veterinary Antiparasitic Drugs Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Veterinary Antiparasitic Drugs Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Veterinary Antiparasitic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Veterinary Antiparasitic Drugs by Type (2020-2031)

Figure 52. Global Revenue Market Share of Veterinary Antiparasitic Drugs by Type (2020-2031)

Figure 53. Global Veterinary Antiparasitic Drugs Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Veterinary Antiparasitic Drugs by Application (2020-2031)

Figure 55. Global Revenue Market Share of Veterinary Antiparasitic Drugs by Application (2020-2031)

Figure 56. Global Veterinary Antiparasitic Drugs Price (US$/Unit) by Application (2020-2031)

Figure 57. Veterinary Antiparasitic Drugs Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions